top of page
News
Press Releases
Inflection Biosciences Announces the Appointment of Professor Martin Dreyling to its Advisory Panel.
Dublin, Ireland, June 4, 2020 Inflection Biosciences Ltd, a company developing innovative small molecule therapeutics for the treatment...
Jun 4, 2020
Inflection Biosciences Announces Participation at Upcoming Industry Conferences.
Dublin, Ireland, May 12th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
May 12, 2020
Inflection Biosciences Announces Appointment of Shaun McNulty, Ph.D., as Chief Scientific Officer.
Dublin, Ireland, February 19th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
Feb 19, 2020
Inflection Biosciences Announces Appointment of Murray Yule, M.D., Ph.D., as Chief Medical Officer
(06 Feb 2020) Dublin, Ireland, February 6th, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the...
Feb 6, 2020
Inflection Biosciences to present at BIO CEO & Investor Conference 2020.
Dublin, Ireland, January 31, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
Jan 31, 2020
Inflection Biosciences Selected as Tech Tour Contest Finalist for 2019
Dublin, Ireland, November 26, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
Nov 26, 2019
bottom of page